Protective Effects of Simvastatin, a Lipid Lowering Agent, against Oxidative Damage in Experimental Diabetic Rats
Figure 1
Effect of simvastatin (SMV) and glibenclamide treatment on serum creatinine (a), blood urea (b), and urinary protein (c), in normal and streptozotocin-induced diabetic rats. Data are expressed as means ± SEM (). *Significantly different from control group (). #Significantly different from diabetic-untreated group ().